$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Oct 14, 2025)
$717.59M
Market Cap
-
P/E Ratio
-1.03
EPS
$8.77
52 Week High
$1.86
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Foster City, California, focused on developing innovative small-molecule therapies aimed at treating nonalcoholic steatohepatitis (NASH) and other serious chronic liver diseases. With a robust pipeline of both single-agent and combination therapy candidates, Terns is at the forefront of addressing unmet medical needs in hepatology. The company’s commitment to advancing its clinical programs positions it as a key player in the biopharmaceutical landscape, potentially offering significant value to investors as it works towards bringing its therapies to market.